US Patent Issued to RVL Pharmaceuticals on April 21 for "Oxymetazoline compositions" (New Jersey Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,363, issued on April 21, was assigned to RVL Pharmaceuticals Inc. (Bridgewater, N.J.).

"Oxymetazoline compositions" was invented by Tina deVries (Bridgewater, N.J.) and David Jacobs (Bernardsville, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to compositions comprising oxymetazoline and methods of stabilizing oxymetazoline compositions for long term storage."

The patent was filed on Dec. 23, 2022, under Application No. 18/146,127.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-b...